Aurones: A Promising Heterocyclic Scaffold for the Development of Potent Antileishmanial Agents

<table>Major fragmentation pathway of chalcones <svg height="15.325" id="M16" style="vertical-align:-2.77095pt" version="1.1" viewbox="0 0 14.2875 15.325" width="14.2875" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,0,0,-.017,.062,11.813)"><path d="M58 524l-21 12q80 152 229 152q73 0 119 -41q45 -41 45 -96q0 -40 -21.5 -74.5t-62.5 -52.5q57 -20 89.5 -68.5t32.5 -109.5q0 -110 -86 -185t-214 -75q-69 0 -110.5 24.5t-41.5 65.5q0 26 18.5 43t46.5 17q45 0 96 -57q39 -43 79 -43q45 0 71.5 34t26.5 88q0 75 -49 121
q-25 23 -56 39q-34 17 -97 38v17q69 21 100 53t31 78q0 103 -99 103q-40 0 -69.5 -19t-56.5 -64z" id="x1D7D1"></path></g><g transform="matrix(.017,0,0,-.017,8.562,11.813)"><path d="M263 613q0 -33 -22.5 -55t-56.5 -22q-33 0 -54.5 22t-21.5 55t22.5 55.5t55.5 22.5q31 0 54 -23t23 -55zM58 461h202v-459q0 -84 -27 -129q-43 -76 -150 -76q-62 0 -101 28t-39 72q0 27 17 44t45 17q25 0 42 -15.5t17 -38.5q0 -15 -14 -37q-9 -15 -9 -22q0 -17 32 -17
q48 0 48 76v474q0 32 -12.5 44t-50.5 15v24z" id="x1D423"></path></g>
</svg>–<svg height="12.0625" id="M17" style="vertical-align:-0.1911pt" version="1.1" viewbox="0 0 13.35 12.0625" width="13.35" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,0,0,-.017,.062,11.763)"><path d="M58 524l-21 12q80 152 229 152q73 0 119 -41q45 -41 45 -96q0 -40 -21.5 -74.5t-62.5 -52.5q57 -20 89.5 -68.5t32.5 -109.5q0 -110 -86 -185t-214 -75q-69 0 -110.5 24.5t-41.5 65.5q0 26 18.5 43t46.5 17q45 0 96 -57q39 -43 79 -43q45 0 71.5 34t26.5 88q0 75 -49 121
q-25 23 -56 39q-34 17 -97 38v17q69 21 100 53t31 78q0 103 -99 103q-40 0 -69.5 -19t-56.5 -64z" id="x1D7D1"></path></g><g transform="matrix(.017,0,0,-.017,8.562,11.763)"><path d="M256 24v-24h-240v24q51 4 51 63v500q0 61 -52 65v24h191v-589q0 -62 50 -63z" id="x1D425"></path></g>
</svg> in CID ESI-MS.</table>

International Journal of Medicinal Chemistry

sch2

Scheme 2

Scheme 2: Aurones: A Promising Heterocyclic Scaffold for the Development of Potent Antileishmanial Agents 